Martin Samuel Bates (CIK 1709024) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-06). Recent activity: Buy CLDX (4,817 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | Celldex Therapeutics, Inc. (CLDX) | SVP AND CFO | Buy | 4,817 | $50,000 |
来源：SEC Form 4 申报文件 · 截至 2026-01-06